PharmStar Pharmaceuticals Update

ROCKY MOUNT, N.C., Aug. 29, 2013 (GLOBE NEWSWIRE) -- The following statement is from Howard Phykitt, President/CEO of PharmStar Pharmaceuticals, Inc. (Pink Sheets:PHAR):

August 22, 2013

Board of Directors
PharmStar Pharmaceuticals, Inc.

Re: Resignation

To Whom It May Concern:

I hereby resign from the position of President, Chief Executive Officer, and Director of PharmStar Pharmaceuticals, Inc. effective immediately.

Upon resignation I will retire 405,000,000 shares of PharmStar Pharmaceuticals, Inc. common stock back to treasury. As compensation for returning the stock, the board of directors has unanimously agreed to release all intellectual property rights, patents and trademarks for soluble aspirin back to Howard Phykitt personally.


Howard Phykitt

CONTACT: PharmStar Pharmaceuticals, Inc. OTC Capital Partners 561-350-8523 www.otccapitalpartners.comSource:PharmStar Pharmaceuticals, Inc.